Pennsylvania Risperdal Breast Verdict Stands, Cut To $680,000; Janssen To Appeal
PHILADELPHIA — Janssen Pharmaceuticals Inc. and Johnson & Johnson on April 1 said they will appeal a Risperdal gynecomastia verdict, even after the court on March 10 reduced the original $1.75...To view the full article, register now.
Already a subscriber? Click here to view full article